[Annual Report] Central and Eastern…
Fierce Biotech: Chinese Vaccine Developer…
Dr. Reddy's, a leading Indian pharmaceutical manufacturer, in partnership with OCT Clinical, an Eastern European CRO, launched a Ph3 neurology study. Despite pandemic-driven uncertainty, the enrollment target of 612 patients was reached within an impressive seven months. Through overcoming many challenges in order to figure out a cohesive strategy and solution, the teams, even within the hurdles caused by the COVID-19 nightmare, managed to undertake all activities within the project on time and complete the recruitment of 612 subjects two weeks ahead of the initially agreed schedule.
Download the case study to find out how the project team managed to complete the task.